Reimbursement Strategies for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the appropriate level of financial support for women with breast cancer who are part of another clinical study and face financial difficulties. Participants will receive monthly payments to cover trial-related costs, with amounts adjusted based on feedback. The study will also conduct interviews to gauge participants' feelings about receiving financial assistance. Women with breast cancer currently enrolled in the I-SPY TRIAL 2 at the UAB Medical Oncology Clinic are well-suited for this trial. As an unphased trial, this study provides a unique opportunity to directly influence the financial support system for future participants.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this reimbursement strategy is safe for patients?
This study does not test a new drug or medical treatment. Instead, it focuses on financial issues, specifically examining the appropriate level of financial support for women with breast cancer participating in a clinical trial. Since the study addresses reimbursement for expenses like travel or lodging, it poses no safety risk. Consequently, there are no concerns about side effects or other health risks.
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores reimbursement strategies for breast cancer treatment-related expenses, which is something quite different from the usual focus on medical or surgical interventions. Unlike standard treatments that target the cancer itself, this approach aims to alleviate the financial burden on patients, potentially making participation in clinical trials more accessible and less stressful. By helping cover trial-related costs, this new strategy may enhance patient engagement and adherence, ultimately leading to better outcomes and more comprehensive data collection.
What evidence suggests that this reimbursement strategy is effective for breast cancer patients?
This trial seeks to determine the appropriate level of financial support for women with breast cancer participating in clinical trials. It does not test a medical treatment, so information about medical effectiveness is unnecessary. Instead, the trial examines how financial assistance can alleviate the stress of trial-related costs. Research has shown that financial support can help patients manage treatment expenses more effectively, potentially enhancing their overall health experience. Participants will receive monthly reimbursements to offset trial-related expenses. The trial will explore the suitable amount of money to provide and assess patients' perceptions of receiving this support.
Who Is on the Research Team?
Courtney Williams, DrPH
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for women with breast cancer who are already part of the I-SPY TRIAL 2 at UAB Medical Oncology Clinic. It's not open to men, non-English speakers, or female patients not enrolled in I-SPY TRIAL 2.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a monthly reimbursement to offset trial-related expenses
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Reimbursement
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor